Headline News about Ionis Pharmaceuticals
![](https://cdn.benzinga.com/files/images/story/2023/04/24/aapharma_3.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/728370/a-doctor-and-patient-at-an-appointment.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/04/12/arwr.png?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Analyst Expectations for Ionis Pharmaceuticals's Future
April 11, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/03/27/azn-ions.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2019/05/Stock-IonisHQ-01-company.jpg)
![](/next-assets/images/schema-image-default.png)
Analyst Ratings for Ionis Pharmaceuticals
March 21, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/ep_us_feature_image_1441.jpeg?width=1200&height=800&fit=crop)
Ionis Pharmaceuticals's Earnings Outlook
February 21, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2079.png?width=1200&height=800&fit=crop)
Analyst Expectations for Ionis Pharmaceuticals's Future
January 19, 2023
Via Benzinga
The Latest Analyst Ratings for Ionis Pharmaceuticals
December 21, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/03/23/biib.png?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/03/16/biib.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/02/21/ions_logo_light__a1a3db690556ba7e6b07c28b193b235b.png?width=1200&height=800&fit=crop)
Ionis Pharmaceuticals Earnings Perspective: Return On Capital Employed
December 13, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_7313.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2018/12/Stock-DrugDesigner-01-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_9525.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For December 21, 2022
December 21, 2022
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2022/11/Stock-neurologybrain-02-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/10/image-phillips_66.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/04/ions_logo_light__a1a3db690556ba7e6b07c28b193b235b.png?width=1200&height=800&fit=crop)
Ionis Regains Rights To Thrombosis Candidate From Bayer
November 04, 2022
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2022/10/A1MAIN_GeneEdit_102122.jpg)
![](https://investorplace.com/wp-content/uploads/2022/04/penny-stocks-sell-bad1600.png)
![](https://www.investors.com/wp-content/uploads/2022/02/Stock-biohavenpharma-01-adobe.jpg)
![](https://www.investors.com/wp-content/uploads/2019/05/Stock-IonisHQ-01-company.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/23/aapharma_6.png?width=1200&height=800&fit=crop)
AstraZeneca Pulls Plug On Ionis Pharma-Partnered Cholesterol Med
September 23, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/09/aapharma_5.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_2985.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/07/bz-pharma_1.jpg?width=1200&height=800&fit=crop)
Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary
September 07, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_26295.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
September 09, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.